MCID: CRB026
MIFTS: 35

Cerebellar Astrocytoma

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Cerebellar Astrocytoma

MalaCards integrated aliases for Cerebellar Astrocytoma:

Name: Cerebellar Astrocytoma 12 15 73
Astrocytoma of Cerebellum 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4848
NCIt 50 C9475
UMLS 73 C0740480

Summaries for Cerebellar Astrocytoma

MalaCards based summary : Cerebellar Astrocytoma, also known as astrocytoma of cerebellum, is related to pilocytic astrocytoma of cerebellum and pilocytic astrocytoma. An important gene associated with Cerebellar Astrocytoma is PNKP (Polynucleotide Kinase 3'-Phosphatase), and among its related pathways/superpathways are Oncogenic MAPK signaling and Central carbon metabolism in cancer. The drugs Prednisone and Vincristine have been mentioned in the context of this disorder. Affiliated tissues include brain, cerebellum and bone, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Related Diseases for Cerebellar Astrocytoma

Diseases related to Cerebellar Astrocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 61)
# Related Disease Score Top Affiliating Genes
1 pilocytic astrocytoma of cerebellum 33.1 IDH1 KIAA1549 MARK3 PNKP
2 pilocytic astrocytoma 31.7 IDH1 KIAA1549
3 cerebellar astrocytoma, childhood 12.1
4 childhood cerebellar astrocytic neoplasm 11.3
5 astrocytoma 10.8
6 medulloblastoma 10.3
7 cerebellum cancer 10.1 PNKP TP53
8 benign glioma 10.0 KIAA1549 TP53
9 nervous system cancer 10.0 IDH1 TP53
10 intracranial chondrosarcoma 10.0 IDH1 TP53
11 mixed glioma 10.0 IDH1 TP53
12 glioma susceptibility 1 10.0 IDH1 TP53
13 periosteal osteogenic sarcoma 10.0 IDH1 TP53
14 leukemia 10.0
15 esotropia 10.0
16 precocious puberty 10.0
17 childhood oligodendroglioma 10.0 IDH1 KIAA1549
18 oligodendroglioma 10.0 IDH1 TP53
19 pleomorphic xanthoastrocytoma 10.0 IDH1 TP53
20 spinal cord astrocytoma 10.0 IDH1 TP53
21 gliomatosis cerebri 10.0 IDH1 TP53
22 adult medulloblastoma 10.0 IDH1 TP53
23 brain glioma 10.0 IDH1 TP53
24 bile duct adenocarcinoma 9.9 IDH1 TP53
25 giant cell glioblastoma 9.9 IDH1 TP53
26 brain stem glioma 9.9 IDH1 TP53
27 intrahepatic cholangiocarcinoma 9.9 IDH1 TP53
28 grade iii astrocytoma 9.9
29 glioblastoma 9.9
30 gliosarcoma 9.9 IDH1 TP53
31 li-fraumeni syndrome 9.9 IDH1 TP53
32 suppression of tumorigenicity 12 9.9 IDH1 TP53
33 alzheimer disease 9.8
34 deafness, unilateral 9.8
35 pick disease of brain 9.8
36 leukemia, acute myeloid 9.8
37 chromosome 18q deletion syndrome 9.8
38 acute leukemia 9.8
39 hydrocephalus 9.8
40 liver disease 9.8
41 asperger syndrome 9.8
42 epilepsy 9.8
43 infantile epileptic encephalopathy 9.8
44 pseudohypoparathyroidism 9.8
45 mutism 9.8
46 optic nerve glioma 9.8
47 myeloid leukemia 9.8
48 meningitis 9.8
49 encephalitis 9.8
50 ependymoma 9.8

Graphical network of the top 20 diseases related to Cerebellar Astrocytoma:



Diseases related to Cerebellar Astrocytoma

Symptoms & Phenotypes for Cerebellar Astrocytoma

GenomeRNAi Phenotypes related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

26 (show all 19)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-12 9.78 TP53
2 Increased shRNA abundance (Z-score > 2) GR00366-A-120 9.78 TP53
3 Increased shRNA abundance (Z-score > 2) GR00366-A-121 9.78 MARK3
4 Increased shRNA abundance (Z-score > 2) GR00366-A-127 9.78 IDH1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-132 9.78 TP53
6 Increased shRNA abundance (Z-score > 2) GR00366-A-136 9.78 IDH1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-138 9.78 IDH1
8 Increased shRNA abundance (Z-score > 2) GR00366-A-147 9.78 IDH1
9 Increased shRNA abundance (Z-score > 2) GR00366-A-169 9.78 TP53
10 Increased shRNA abundance (Z-score > 2) GR00366-A-172 9.78 IDH1 MARK3
11 Increased shRNA abundance (Z-score > 2) GR00366-A-185 9.78 MARK3
12 Increased shRNA abundance (Z-score > 2) GR00366-A-19 9.78 TP53
13 Increased shRNA abundance (Z-score > 2) GR00366-A-190 9.78 MARK3 TP53
14 Increased shRNA abundance (Z-score > 2) GR00366-A-21 9.78 MARK3
15 Increased shRNA abundance (Z-score > 2) GR00366-A-35 9.78 TP53
16 Increased shRNA abundance (Z-score > 2) GR00366-A-39 9.78 IDH1 TP53
17 Increased shRNA abundance (Z-score > 2) GR00366-A-47 9.78 IDH1
18 Increased shRNA abundance (Z-score > 2) GR00366-A-67 9.78 MARK3
19 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.78 MARK3

MGI Mouse Phenotypes related to Cerebellar Astrocytoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.02 IDH1 KIAA1549 MARK3 PNKP TP53

Drugs & Therapeutics for Cerebellar Astrocytoma

Drugs for Cerebellar Astrocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 195)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisone Approved, Vet_approved Phase 3,Phase 2 53-03-2 5865
2
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 57-22-7, 2068-78-2 5978
3
Methotrexate Approved Phase 3,Phase 2 59-05-2, 1959-05-2 126941
4
leucovorin Approved Phase 3,Phase 2 58-05-9 6006 143
5
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1 51-75-2 4033
6
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
7
Levoleucovorin Approved, Investigational Phase 3,Phase 2 68538-85-2
8
Lomustine Approved, Investigational Phase 3,Phase 1 13010-47-4 3950
9
Etoposide Approved Phase 3,Phase 1,Phase 2,Not Applicable 33419-42-0 36462
10
Ifosfamide Approved Phase 3,Phase 1,Phase 2 3778-73-2 3690
11
Carboplatin Approved Phase 3,Phase 2,Phase 1,Not Applicable 41575-94-4 10339178 38904 498142
12
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 6055-19-2, 50-18-0 2907
13
Thiotepa Approved, Investigational Phase 3,Phase 2,Phase 1 52-24-4 5453
14
Lenograstim Approved, Investigational Phase 3,Phase 1,Phase 2 135968-09-1
15
Temozolomide Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 85622-93-1 5394
16
Isotretinoin Approved Phase 3 4759-48-2 5538 5282379
17
Thioguanine Approved Phase 3 154-42-7 2723601
18
Procarbazine Approved, Investigational Phase 3,Phase 2,Phase 1 671-16-9 4915
19
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 1177-87-3
20
Ondansetron Approved Phase 3 99614-02-5 4595
21
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
22
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
23
Histamine Approved, Investigational Phase 3,Phase 2 51-45-6, 75614-87-8 774
24
Cyproheptadine Approved Phase 3,Phase 2 129-03-3 2913
25
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2 59-30-3 6037
26
Tretinoin Approved, Investigational, Nutraceutical Phase 3 302-79-4 5538 444795
27
Isophosphamide mustard Phase 3,Phase 1,Phase 2 0
28 Hormone Antagonists Phase 3,Phase 2,Phase 1
29 Antirheumatic Agents Phase 3,Phase 2,Phase 1
30 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
31 Antimetabolites Phase 3,Phase 2,Phase 1
32 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1,Not Applicable
33 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Phase 1,Not Applicable
34 Hormones Phase 3,Phase 2,Phase 1
35 Immunologic Factors Phase 3,Phase 2,Phase 1,Not Applicable
36 Calcium, Dietary Phase 3,Phase 2
37 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
38 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1,Not Applicable
39 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
40 Folic Acid Antagonists Phase 3,Phase 2
41 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
42 Vitamin B9 Phase 3,Phase 2
43 Alkylating Agents Phase 3,Phase 2,Phase 1,Not Applicable
44 Vitamin B Complex Phase 3,Phase 2
45 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
46 Etoposide phosphate Phase 3,Phase 1,Phase 2,Not Applicable
47 Antimitotic Agents Phase 3,Phase 2,Phase 1,Not Applicable
48 Folate Phase 3,Phase 2
49 glucocorticoids Phase 3,Phase 2,Phase 1
50 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 101)
# Name Status NCT ID Phase Drugs
1 Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas Unknown status NCT00278278 Phase 3 cisplatin;etoposide;ifosfamide;lomustine;methotrexate;prednisone;vincristine sulfate
2 Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma Unknown status NCT00003015 Phase 3 carboplatin;vincristine sulfate
3 Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors Unknown status NCT00392886 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide;methotrexate;temozolomide;thiotepa;vincristine sulfate
4 High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas Completed NCT00078988 Phase 3 carboplatin;etoposide;isotretinoin;thiotepa
5 Combination Chemotherapy in Treating Children With Progressive Brain Tumors Completed NCT00002944 Phase 3 carboplatin;lomustine;procarbazine hydrochloride;thioguanine;vincristine sulfate
6 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
7 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
8 Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors Unknown status NCT00313521 Phase 2 thiotepa
9 Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma Unknown status NCT00005084 Phase 2
10 Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma Unknown status NCT00360945 Phase 2 cisplatin;temozolomide
11 Radiation Therapy in Treating Young Patients With Gliomas Unknown status NCT00238264 Phase 2
12 Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors Unknown status NCT00281905 Phase 2 carboplatin;cisplatin;cyclophosphamide;methotrexate;vincristine sulfate
13 Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor Completed NCT00004068 Phase 2 irinotecan hydrochloride;temozolomide
14 Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy Completed NCT00679354 Phase 2 cilengitide
15 Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma Completed NCT01462695 Phase 2 Sunitinib Malate
16 Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma Completed NCT00070525 Phase 2 tipifarnib
17 Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Completed NCT00091182 Phase 2 oxaliplatin
18 Irinotecan in Treating Children With Refractory Solid Tumors Completed NCT00004078 Phase 2 irinotecan hydrochloride
19 Carboplatin in Patients With Progressive Gliomas Completed NCT00002749 Phase 2 carboplatin
20 Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors Completed NCT00002463 Phase 2 MOPP Regimen;Leucovorin Calcium;Mechlorethamine Hydrochloride;Methotrexate;Prednisone;Procarbazine Hydrochloride;Vincristine Sulfate
21 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Completed NCT00066248 Phase 2 cyproheptadine hydrochloride;megestrol acetate
22 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors Completed NCT00005952 Phase 1, Phase 2 temozolomide
23 Lobradimil and Carboplatin in Treating Children With Brain Tumors Completed NCT00019422 Phase 2 carboplatin;lobradimil
24 Vinorelbine in Treating Children With Recurrent or Refractory Cancers Completed NCT00003234 Phase 2 vinorelbine tartrate
25 Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors Completed NCT00003241 Phase 2 phenylacetate
26 Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma Completed NCT00124657 Phase 1, Phase 2 Erlotinib hydrochloride
27 Docetaxel in Treating Children With Recurrent Solid Tumors Completed NCT00002825 Phase 2 docetaxel
28 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers Completed NCT00002752 Phase 1, Phase 2
29 Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma Completed NCT00008008 Phase 2 cyclophosphamide;thiotepa
30 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00006102 Phase 2 becatecarin
31 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Completed NCT00005955 Phase 2 temozolomide
32 Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors Completed NCT00002608 Phase 2 cisplatin;doxorubicin hydrochloride;tamoxifen citrate
33 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Active, not recruiting NCT00445965 Phase 2
34 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
35 Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma Unknown status NCT00360854 Phase 1 erlotinib hydrochloride
36 Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors Unknown status NCT00007813 Phase 1 carboplatin;cyclophosphamide;etoposide
37 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1 verteporfin
38 Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma Completed NCT00357253 Phase 1 capecitabine
39 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Completed NCT01076530 Phase 1 vorinostat;temozolomide
40 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1 veliparib;temozolomide
41 Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Completed NCT00100880 Phase 1 lenalidomide
42 Cilengitide in Treating Children With Refractory Primary Brain Tumors Completed NCT00063973 Phase 1 cilengitide
43 Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors Completed NCT00052780 Phase 1 O6-benzylguanine;temozolomide
44 Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas Completed NCT00012181 Phase 1 alvocidib
45 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
46 Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors Completed NCT00077454 Phase 1 erlotinib hydrochloride;temozolomide
47 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Completed NCT00994500 Phase 1 vorinostat;bortezomib
48 Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma Completed NCT00363272 Phase 1 ispinesib
49 AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Completed NCT00326664 Phase 1 Cediranib Maleate
50 Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas Completed NCT00101270 Phase 1 irinotecan hydrochloride;oxaliplatin

Search NIH Clinical Center for Cerebellar Astrocytoma

Genetic Tests for Cerebellar Astrocytoma

Anatomical Context for Cerebellar Astrocytoma

MalaCards organs/tissues related to Cerebellar Astrocytoma:

41
Brain, Cerebellum, Bone, Liver, Myeloid, Bone Marrow, Spinal Cord

Publications for Cerebellar Astrocytoma

Articles related to Cerebellar Astrocytoma:

(show top 50) (show all 97)
# Title Authors Year
1
Giant congenital melanocytic nevus associated with cerebellar astrocytoma. ( 29619995 )
2018
2
Post-operative accidental diagnosis of intra-cerebellar astrocytoma in an emergency appendicectomy case. ( 26962259 )
2016
3
Pediatric cerebellar astrocytoma: a review. ( 26351221 )
2015
4
Cerebellar astrocytoma presenting with headache and nystagmus in a 20-year-old male. ( 24485699 )
2014
5
Neurosurgical treatment of low-grade cerebellar astrocytoma in children and adolescents: a single consecutive institutional series of 100 patients. ( 23240848 )
2013
6
Simultaneous conus medullaris ependymoma and cerebellar astrocytoma in the same patient. ( 19537133 )
2009
7
Postoperative surveillance magnetic resonance imaging for cerebellar astrocytoma. ( 19960748 )
2009
8
Outcome of children with low-grade cerebellar astrocytoma: long-term complications and quality of life. ( 18690461 )
2008
9
Differential prefrontal-like deficit in children after cerebellar astrocytoma and medulloblastoma tumor. ( 18412947 )
2008
10
Cerebellar astrocytoma presenting with precocious puberty in a girl. Case report. ( 17644924 )
2007
11
Hemifacial spasm as the initial manifestation of childhood cerebellar astrocytoma. ( 17070492 )
2006
12
Spontaneous regression of cerebellar astrocytoma after subtotal resection. ( 16552566 )
2006
13
Epilepsy and neuropsychologic deficit in a child with cerebellar astrocytoma. ( 16970895 )
2006
14
Long-term effects of transient cerebellar mutism after cerebellar astrocytoma or medulloblastoma tumor resection in childhood. ( 16155765 )
2006
15
Long-term sequelae in children after cerebellar astrocytoma surgery. ( 15111667 )
2004
16
Difficulties in the diagnosis of cerebellar astrocytoma-induced deafness in infancy: a case report. ( 15100653 )
2004
17
Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: contribution to noninvasive differential diagnosis with cerebellar astrocytoma. ( 15458590 )
2004
18
Sub-classification of low-grade cerebellar astrocytoma: is it clinically meaningful? ( 14631523 )
2003
19
Unilateral deafness with persistent otoacoustic emissions after neurosurgical removal of a cerebellar astrocytoma. ( 11226965 )
2001
20
Evolution of malignant cerebellar astrocytoma at the site of a treated medulloblastoma: report of two cases. ( 11534690 )
2001
21
Hypernasality--a rare initial symptom of a cerebellar astrocytoma. ( 11035179 )
2000
22
Contralateral cortical diaschisis in a patient with cerebellar astrocytoma after radiation therapy. ( 10836690 )
2000
23
Human herpesvirus-6 associated encephalitis with subsequent infantile spasms and cerebellar astrocytoma. ( 10875530 )
2000
24
Cerebellar astrocytoma in an adult with extensive leptomeningeal spread. ( 11045208 )
2000
25
Cerebellar astrocytoma associated with von Hippel-Lindau disease: case report with molecular findings. ( 10627785 )
1999
26
Cerebellar astrocytoma presenting with acute esotropia in a 5 year-old girl. Case report. ( 11456255 )
1999
27
[Development of cerebellar astrocytoma in a patient with acute myeloid leukemia 8 years after his second bone marrow transplant]. ( 10390894 )
1999
28
Cerebellar astrocytoma and Asperger syndrome. ( 10461572 )
1999
29
Predicting disease progression in childhood cerebellar astrocytoma. ( 9840364 )
1998
30
Intraventricular and leptomeningeal dissemination of a pilocytic cerebellar astrocytoma in a child with a ventriculoperitoneal shunt: case report. ( 11013652 )
1998
31
Palatal myoclonus induced by extirpation of a cerebellar astrocytoma. Case report. ( 9609309 )
1998
32
Malignant cerebellar astrocytoma developing 15 years after radiation therapy for a medulloblastoma. ( 9637208 )
1998
33
Cerebellar astrocytoma: experience with 54 cases surgically treated at the Mayo Clinic, Rochester, Minnesota, from 1978 to 1990. ( 9254090 )
1997
34
Rapidly growing calcified cerebellar astrocytoma in infants. ( 8674077 )
1996
35
Cerebellar astrocytoma manifesting as isolated, comitant esotropia in childhood. ( 8610811 )
1996
36
Cerebellar astrocytoma: report of 13 cases aged over 20 years and review of the literature. ( 8864501 )
1996
37
Radiology rounds. Cerebellar astrocytoma. ( 7580377 )
1995
38
Cerebellar astrocytoma of childhood: long-term follow-up. ( 7758018 )
1995
39
Benign cerebellar astrocytoma in childhood: experience at the Hospital for Sick Children 1980-1992. ( 7842424 )
1994
40
Bilateral fluctuating trochlear nerve palsy secondary to cerebellar astrocytoma. ( 8180876 )
1994
41
Cerebellar astrocytoma with extensive lipidization mimicking adipose tissue. ( 7847080 )
1994
42
Ring chromosome 12 resulting from nonrandom telomeric associations with the short arm of chromosome 15 in a cerebellar astrocytoma. ( 7504519 )
1993
43
Pilocytic cerebellar astrocytoma in adults: case report. ( 8493594 )
1993
44
Prolonged I-III interwave interval in cerebellar astrocytoma. ( 8369545 )
1993
45
Results of post-operative or exclusive radiotherapy in grade I and grade II cerebellar astrocytoma patients. ( 1609128 )
1992
46
Cerebellar astrocytoma with repeated episodes of fourth ventricle isolation causing peritoneal shunt tube obstruction--case report. ( 1381063 )
1992
47
"One-and-a-half" syndrome after a resection of a midline cerebellar astrocytoma: case report and discussion of the literature. ( 1961411 )
1991
48
Bilateral symmetrical striopallidodentate calcification associated with pseudohypoparathyroidism demonstrated in a patient with cerebellar astrocytoma. ( 2034361 )
1991
49
Benign recurrence of a pilocytic cerebellar astrocytoma 36 years after radical removal: case report. ( 2034360 )
1991
50
Importance of histologic condition and treatment of pediatric cerebellar astrocytoma. ( 1851047 )
1991

Variations for Cerebellar Astrocytoma

Expression for Cerebellar Astrocytoma

Search GEO for disease gene expression data for Cerebellar Astrocytoma.

Pathways for Cerebellar Astrocytoma

Pathways related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.09 KIAA1549 MARK3
2 10.44 IDH1 TP53

GO Terms for Cerebellar Astrocytoma

Biological processes related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to oxidative stress GO:0006979 8.62 IDH1 PNKP

Sources for Cerebellar Astrocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....